Purchases and Sales Made in Q4 2024 in Arrowhead Pharmaceuticals, Inc. (ARWR)
This table provides information about the institutional ownership of Arrowhead Pharmaceuticals, Inc. (ARWR) during Q4 2024. The information is specifically focused on institutions that hold shares of ARROWHEAD PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2025
Q4 2024
|
Center Book Partners LP
Greenwich, CT |
SELL
|
- |
-44.1K- 11.18% |
$781K - $1.16M
|
350K
$6.62M
|
|
|
Feb 11, 2025
Q4 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-44.8K- 0.37% |
$792K - $1.18M
|
12.2M
$230M
|
|
|
Feb 14, 2025
Q4 2024
|
Hudson Bay Capital Management LP
Greenwich, CT |
SELL
|
- |
-45K- 20.45% |
$797K - $1.19M
|
175K
$3.3M
|
|
|
Feb 07, 2025
Q4 2024
|
High Tower Advisors, LLC
Chicago, IL |
SELL
|
- |
-48.4K- 39.21% |
$857K - $1.28M
|
75.1K
$1.42M
|
|
|
Feb 14, 2025
Q4 2024
|
Hound Partners, LLC
New York, NY |
SELL
|
- |
-53.2K- 14.04% |
$941K - $1.4M
|
326K
$6.15M
|
|
|
Feb 13, 2025
Q4 2024
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-66.6K- 27.44% |
$1.18M - $1.76M
|
176K
$3.33M
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-69.4K- 4.32% |
$1.23M - $1.83M
|
1.54M
$29M
|
|
|
Feb 12, 2025
Q4 2024
|
Trexquant Investment LP
Stamford, CT |
SELL
|
- |
-85.9K- 46.01% |
$1.52M - $2.26M
|
101K
$1.9M
|
|
|
Feb 13, 2025
Q4 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-86.2K- 70.74% |
$1.53M - $2.27M
|
35.7K
$673K
|
|
|
Feb 14, 2025
Q4 2024
|
Aquilo Capital Management, LLC
San Francisco, CA |
SELL
|
- |
-88.2K- 11.09% |
$1.56M - $2.32M
|
708K
$13.4M
|
|
|
Feb 14, 2025
Q4 2024
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-108K- 55.6% |
$1.91M - $2.84M
|
86K
$1.62M
|
|
|
Feb 10, 2025
Q4 2024
|
Campbell & CO Investment Adviser LLC
Baltimore, MD |
SELL
|
- |
-125K- 86.67% |
$2.21M - $3.28M
|
19.2K
$362K
|
|
|
Feb 13, 2025
Q4 2024
|
Altium Capital Management LP
New York, NY |
SELL
|
- |
-125K- 35.14% |
$2.21M - $3.29M
|
230K
$4.35M
|
|
|
Feb 12, 2025
Q4 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-128K- 5.96% |
$2.27M - $3.37M
|
2.02M
$38.1M
|
|
|
Feb 13, 2025
Q4 2024
|
Capital International Investors
Los Angeles, CA |
SELL
|
- |
-130K- 50.67% |
$2.29M - $3.41M
|
126K
$2.38M
|
|
|
Feb 13, 2025
Q4 2024
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-132K- 41.88% |
$2.34M - $3.48M
|
183K
$3.46M
|
|
|
Feb 14, 2025
Q4 2024
|
Ubs Asset Management Americas Inc
Chicago, IL |
SELL
|
- |
-144K- 6.69% |
$2.55M - $3.8M
|
2.01M
$38M
|
|
|
Jan 14, 2025
Q4 2024
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-240K- 81.91% |
$4.25M - $6.32M
|
53K
$1M
|
|
|
Feb 14, 2025
Q4 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-247K- 82.09% |
$4.36M - $6.49M
|
53.8K
$1.02M
|
|
|
Feb 14, 2025
Q4 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-338K- 5.32% |
$5.98M - $8.91M
|
6.02M
$114M
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-810K- 68.75% |
$14.3M - $21.3M
|
368K
$6.95M
|
|
|
Feb 14, 2025
Q4 2024
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
SELL
|
- |
-1.07M- 29.86% |
$18.9M - $28.1M
|
2.51M
$47.3M
|